Invention Grant
- Patent Title: Eicosapentaenoic acid (EPA) formulations
-
Application No.: US14651665Application Date: 2013-12-18
-
Publication No.: US10123986B2Publication Date: 2018-11-13
- Inventor: Brian J. Waibel , Hans Schonemann , Val Krukonis , Michael Kagan
- Applicant: Brian J. Waibel , Hans Schonemann , Val Krukonis , Michael Kagan
- Applicant Address: US TX Houston
- Assignee: Qualitas Health, Ltd.
- Current Assignee: Qualitas Health, Ltd.
- Current Assignee Address: US TX Houston
- Agency: Weaver Austin Villeneuve & Sampson LLP
- International Application: PCT/US2013/076178 WO 20131218
- International Announcement: WO2014/105576 WO 20140703
- Main IPC: A61K31/202
- IPC: A61K31/202 ; A23L2/52 ; A61K36/02 ; A23L33/12 ; C11B1/10 ; A61K31/122 ; A61K47/48
Abstract:
Provided herein are compositions comprising eicosapentaenoic acid (EPA) and polar lipids (e.g., glycolipids and phospholipids), and which do not contain any docosahexaenoic acid (DHA) or esterified fatty acids.
Public/Granted literature
- US20170035719A1 EICOSAPENTAENOIC ACID (EPA) FORMULATIONS Public/Granted day:2017-02-09
Information query
IPC分类:
